Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

The role of SCARB2 as susceptibility factor in Parkinson's disease.

Hopfner F, Schulte EC, Mollenhauer B, Bereznai B, Knauf F, Lichtner P, Zimprich A, Haubenberger D, Pirker W, Brücke T, Peters A, Gieger C, Kuhlenbäumer G, Trenkwalder C, Winkelmann J.

Mov Disord. 2013 Apr;28(4):538-40. doi: 10.1002/mds.25349. Epub 2013 Feb 13.

PMID:
23408458
2.

Association study of SCARB2 rs6812193 polymorphism with Parkinson's disease in Han Chinese.

Chen S, Zhang Y, Chen W, Wang Y, Liu J, Rong TY, Ma JF, Wang G, Zhang J, Pan J, Xiao Q, Chen SD.

Neurosci Lett. 2012 May 10;516(1):21-3. doi: 10.1016/j.neulet.2012.03.035. Epub 2012 Mar 23.

PMID:
22465138
3.

Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data.

Maniwang E, Tayebi N, Sidransky E.

Mol Genet Metab. 2013 Apr;108(4):269-71. doi: 10.1016/j.ymgme.2013.01.012. Epub 2013 Jan 29.

4.

Association study of rs6812193 polymorphism with Parkinson's disease in a Greek population.

Kalinderi K, Bostantjopoulou S, Katsarou Z, Fidani L.

Neurosci Lett. 2013 Apr 29;541:190-2. doi: 10.1016/j.neulet.2013.02.048. Epub 2013 Mar 7.

PMID:
23473716
5.

Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease.

Michelakakis H, Xiromerisiou G, Dardiotis E, Bozi M, Vassilatis D, Kountra PM, Patramani G, Moraitou M, Papadimitriou D, Stamboulis E, Stefanis L, Zintzaras E, Hadjigeorgiou GM.

Mov Disord. 2012 Mar;27(3):400-5. doi: 10.1002/mds.24886. Epub 2012 Jan 5.

PMID:
22223122
6.

No association of FAM47E rs6812193, SCARB2 rs6825004 and STX1B rs4889603 polymorphisms with Parkinson's disease in a Chinese Han population.

Chen Y, Yuan X, Cao B, Wei Q, Ou R, Yang J, Chen X, Zhao B, Song W, Wu Y, Shang H.

J Neural Transm (Vienna). 2015 Nov;122(11):1547-52. doi: 10.1007/s00702-015-1430-4. Epub 2015 Jul 30.

PMID:
26224037
7.

Association between rs6812193 polymorphism and sporadic Parkinson's disease susceptibility.

Huo Q, Li T, Zhao P, Wang L.

Neurol Sci. 2015 Aug;36(8):1479-81. doi: 10.1007/s10072-015-2186-1. Epub 2015 Mar 29.

PMID:
25820215
8.

Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease.

Lesage S, Anheim M, Condroyer C, Pollak P, Durif F, Dupuits C, Viallet F, Lohmann E, Corvol JC, Honoré A, Rivaud S, Vidailhet M, Dürr A, Brice A; French Parkinson's Disease Genetics Study Group.

Hum Mol Genet. 2011 Jan 1;20(1):202-10. doi: 10.1093/hmg/ddq454. Epub 2010 Oct 14.

PMID:
20947659
9.

SCARB2 variants and glucocerebrosidase activity in Parkinson's disease.

Alcalay RN, Levy OA, Wolf P, Oliva P, Zhang XK, Waters CH, Fahn S, Kang U, Liong C, Ford B, Mazzoni P, Kuo S, Johnson A, Xiong L, Rouleau GA, Chung W, Marder KS, Gan-Or Z.

NPJ Parkinsons Dis. 2016;2. pii: 16004. Epub 2016 Mar 10.

10.

Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.

De Marco EV, Annesi G, Tarantino P, Rocca FE, Provenzano G, Civitelli D, Cirò Candiano IC, Annesi F, Carrideo S, Condino F, Nicoletti G, Messina D, Novellino F, Morelli M, Quattrone A.

Mov Disord. 2008 Feb 15;23(3):460-3.

PMID:
18074383
11.

Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.

Clark LN, Ross BM, Wang Y, Mejia-Santana H, Harris J, Louis ED, Cote LJ, Andrews H, Fahn S, Waters C, Ford B, Frucht S, Ottman R, Marder K.

Neurology. 2007 Sep 18;69(12):1270-7.

12.

Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population.

Choi JM, Kim WC, Lyoo CH, Kang SY, Lee PH, Baik JS, Koh SB, Ma HI, Sohn YH, Lee MS, Kim YJ.

Neurosci Lett. 2012 Apr 11;514(1):12-5. doi: 10.1016/j.neulet.2012.02.035. Epub 2012 Feb 22.

PMID:
22387070
13.

Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features.

Hopfner F, Schormair B, Knauf F, Berthele A, Tölle TR, Baron R, Maier C, Treede RD, Binder A, Sommer C, Maihöfner C, Kunz W, Zimprich F, Heemann U, Pfeufer A, Näbauer M, Kääb S, Nowak B, Gieger C, Lichtner P, Trenkwalder C, Oexle K, Winkelmann J.

BMC Neurol. 2011 Oct 27;11:134. doi: 10.1186/1471-2377-11-134.

14.

Analysis of the glucocerebrosidase gene in Parkinson's disease.

Sato C, Morgan A, Lang AE, Salehi-Rad S, Kawarai T, Meng Y, Ray PN, Farrer LA, St George-Hyslop P, Rogaeva E.

Mov Disord. 2005 Mar;20(3):367-70.

PMID:
15517592
15.

Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.

Winder-Rhodes SE, Evans JR, Ban M, Mason SL, Williams-Gray CH, Foltynie T, Duran R, Mencacci NE, Sawcer SJ, Barker RA.

Brain. 2013 Feb;136(Pt 2):392-9. doi: 10.1093/brain/aws318.

PMID:
23413260
16.

Parkinson's Disease Genetic Loci in Rapid Eye Movement Sleep Behavior Disorder.

Gan-Or Z, Girard SL, Noreau A, Leblond CS, Gagnon JF, Arnulf I, Mirarchi C, Dauvilliers Y, Desautels A, Mitterling T, Cochen De Cock V, Frauscher B, Monaca C, Hogl B, Dion PA, Postuma RB, Montplaisir JY, Rouleau GA.

J Mol Neurosci. 2015 Jul;56(3):617-22. doi: 10.1007/s12031-015-0569-7. Epub 2015 May 1.

PMID:
25929833
17.

Genetic association study of synphilin-1 in idiopathic Parkinson's disease.

Myhre R, Klungland H, Farrer MJ, Aasly JO.

BMC Med Genet. 2008 Mar 21;9:19. doi: 10.1186/1471-2350-9-19.

18.

Mutations for Gaucher disease confer high susceptibility to Parkinson disease.

Mitsui J, Mizuta I, Toyoda A, Ashida R, Takahashi Y, Goto J, Fukuda Y, Date H, Iwata A, Yamamoto M, Hattori N, Murata M, Toda T, Tsuji S.

Arch Neurol. 2009 May;66(5):571-6. doi: 10.1001/archneurol.2009.72.

PMID:
19433656
19.

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.

Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jan 27;72(4):310-6. doi: 10.1212/01.wnl.0000327823.81237.d1. Epub 2008 Nov 5.

20.

A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy.

Higashiyama Y, Doi H, Wakabayashi M, Tsurusaki Y, Miyake N, Saitsu H, Ohba C, Fukai R, Miyatake S, Joki H, Koyano S, Suzuki Y, Tanaka F, Kuroiwa Y, Matsumoto N.

Mov Disord. 2013 Apr;28(4):552-3. doi: 10.1002/mds.25296. Epub 2013 Jan 16. No abstract available.

PMID:
23325613

Supplemental Content

Support Center